Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,348 | -2,903 | -12,093 | -8,832 | -5,291 |
| Other Working Capital | 1,133 | 71 | 1,248 | 296 | -242 |
| Other Operating Activity | 1,706 | 899 | 3,302 | 2,490 | 1,666 |
| Operating Cash Flow | $-3,510 | $-1,933 | $-7,542 | $-6,047 | $-3,867 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 3,544 | 0 | 3,695 | 3,695 | 0 |
| Financing Cash Flow | $3,544 | $0 | $3,695 | $3,695 | $0 |
| Beginning Cash Position | 9,112 | 9,112 | 12,959 | 12,959 | 12,959 |
| End Cash Position | 9,146 | 7,179 | 9,112 | 10,607 | 9,092 |
| Net Cash Flow | $34 | $-1,933 | $-3,847 | $-2,352 | $-3,867 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,510 | -1,933 | -7,542 | -6,047 | -3,867 |
| Free Cash Flow | -3,510 | -1,933 | -7,542 | -6,047 | -3,867 |